NCT02570113 - The Peregrine Post-Market Study for the Treatment of Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

July 31, 2019

Conditions

Hypertension

Interventions

DEVICE

Peregrine System Infusion Catheter

The Peregrine Catheter is inserted bilaterally into the renal arteries and a specified amount of a neurolytic agent is inserted into the vessel walls.

Trial Locations (10)

1200

Cliniques Universitaires Saint-Luc, Brussels

12203

Charite-Universitaetsmedizin Berlin, Berlin

45138

Elisabeth-Krankenhause, Essen

60389

CardioVasculares Centrum (CVC) Frankfurt, Frankfurt

66421

Klinik fur Innere Medizin III, Homburg

79106

Universitats-Herzzentrum/University Heart Center Klinik fur Kardiologie und Angiologie, Freiburg im Breisgau

91054

Universitätsklinik Erlangen Klinik für Nephrologie/Hypertensiologie, Erlangen

150 30

Na Homolce Hospital, Prague

43-100

Oddzial Kardiologii Inwazyjnej, Tychy

43-450

Oddizal Kardiologiczno-Angiologiczny PAKS, Ustroń